Skip to main content
Completed Clinical Trials

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

By April 24, 2017No Comments

Condition

Malignant Mesothelioma|Pulmonary Complications

Estimated Enrollment: 494

Age Group: 25 Years to 80 Years   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Case Control|Time Perspective: Prospective

Study ID Numbers: CDR0000518348|P30CA022453|WSU-2006-057|WSU-HIC-094806MP2F

Study First Received: May 9, 2009

Last Updated: March 4, 2014

Estimated Primary Completion Date: March 2013

 

Primary Outcome Measures:

Identification of potential drug targets for therapeutic strategies to treat asbestos fiber-related diseases

Sponsors and Collaborators:

Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00897247

Leave a Reply